Iboga, more commonly known as ibogaine, is a psychedelic property derived from a plant that is found on the African continent. It has recently gained some attention among medical professionals throughout the world for its possible benefits for those who have had struggled with narcotic or opiate addiction. Treating such individuals with iboga is said to interrupt the person's addictive tendencies.
This interruption of addictive behavioral patterns is thought to work by resetting the individual's neurotransmitters to their preaddicted state. This in turn is thought to eliminate the person's craving for his or her drug of choice. As one might suspect, however, the treatment is still quite controversial among traditional healthcare practitioners.
The reason for such skepticism is based on the fact that most of the research that was completed on iboga was not overseen by an unbiased third party. However, certain clients have claimed that the treatment helped them when conventional rehabilitation methods failed. There are certain individuals who state that such testimonies should not be overlooked.
The therapy centers entirely on changing the person's state of mind who is fighting the addiction. The goal is to mentally take him or her to an era of time prior to the occurrence of the drug dependency. Proponents of the treatment claimed that when the patient has reached this state, it makes it possible for him or her to examine personal behavioral patterns and habits from a nonaddict's perspective.
In addition, people who promote the treatment state that medications manufactured from the iboga plant will also considerably lessen the number of withdrawal symptoms experienced in individuals who are going through rehabilitation. It is believed that this will benefit everyone who undergoes treatment, regardless of the severity of their addiction.
Many drugs that are used to treat withdrawal symptoms are of little help regarding the control of post-treatment cravings. However, ibogaine users who previously enrolled in conventional rehabilitation programs state that they feel much more in control than they did in the past when traditional post-treatment medications were prescribed.
In addition to the information outlined above, the controversy surrounding ibogaine stems from the fact that it contains psychedelic properties. Many medical professionals believe that substituting a narcotic or opiate with a psychedelic drug is just replacing one addiction for another. They base this belief on the potential for abuse associated with iboga.
This is why in most countries throughout the world, healthcare professionals are in agreement that additional research is necessary with regard to the therapeutic uses of the drug. Studies of this kind are generally best conducted in a conventional clinical environment where the medicine's effectiveness can be researched in a systematic way. Because of its psychedelic properties and subsequent unpredictable side effects, it is scheduled as a controlled substance in numerous nations around the world, such as the United States, Germany and Switzerland.
Based on the drug's potency and how it affects the chemical balances in the patient's body, it requires a prescription and should only be administered by a qualified doctor or other healthcare practitioner. A person should never attempt to manage his or her own therapy or take the medication without a doctor's supervision. In addition, it is imperative to seek follow-up care after being treated with ibogaine.
This interruption of addictive behavioral patterns is thought to work by resetting the individual's neurotransmitters to their preaddicted state. This in turn is thought to eliminate the person's craving for his or her drug of choice. As one might suspect, however, the treatment is still quite controversial among traditional healthcare practitioners.
The reason for such skepticism is based on the fact that most of the research that was completed on iboga was not overseen by an unbiased third party. However, certain clients have claimed that the treatment helped them when conventional rehabilitation methods failed. There are certain individuals who state that such testimonies should not be overlooked.
The therapy centers entirely on changing the person's state of mind who is fighting the addiction. The goal is to mentally take him or her to an era of time prior to the occurrence of the drug dependency. Proponents of the treatment claimed that when the patient has reached this state, it makes it possible for him or her to examine personal behavioral patterns and habits from a nonaddict's perspective.
In addition, people who promote the treatment state that medications manufactured from the iboga plant will also considerably lessen the number of withdrawal symptoms experienced in individuals who are going through rehabilitation. It is believed that this will benefit everyone who undergoes treatment, regardless of the severity of their addiction.
Many drugs that are used to treat withdrawal symptoms are of little help regarding the control of post-treatment cravings. However, ibogaine users who previously enrolled in conventional rehabilitation programs state that they feel much more in control than they did in the past when traditional post-treatment medications were prescribed.
In addition to the information outlined above, the controversy surrounding ibogaine stems from the fact that it contains psychedelic properties. Many medical professionals believe that substituting a narcotic or opiate with a psychedelic drug is just replacing one addiction for another. They base this belief on the potential for abuse associated with iboga.
This is why in most countries throughout the world, healthcare professionals are in agreement that additional research is necessary with regard to the therapeutic uses of the drug. Studies of this kind are generally best conducted in a conventional clinical environment where the medicine's effectiveness can be researched in a systematic way. Because of its psychedelic properties and subsequent unpredictable side effects, it is scheduled as a controlled substance in numerous nations around the world, such as the United States, Germany and Switzerland.
Based on the drug's potency and how it affects the chemical balances in the patient's body, it requires a prescription and should only be administered by a qualified doctor or other healthcare practitioner. A person should never attempt to manage his or her own therapy or take the medication without a doctor's supervision. In addition, it is imperative to seek follow-up care after being treated with ibogaine.
About the Author:
You can visit the website www.ibogapath.com for more helpful information about Different Views About Ibogaine Therapy
No comments:
Post a Comment